Synapse - Works

Results (5608)

Association of alkaline phosphatase with clinical outcomes in chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC): Results from COU-AA-302

Meeting Abstract

Mainwaring, P.; Yu, E. Y.; Londhe, A.; Van Poppel, H.; Rathkopf, D. E.; Smith, M. R.; Souza, P.; Griffin, T. W.; Ryan, C. J.
BJU International (2014)

Fulltext@MSK | Save

Src pathway activation in RCC and the correlation with grade and survival and the development of a rational new target in RCC

Meeting Abstract

Lee, C. H.; Voss, M. H.; Mano, R.; Motzer, R. J.; Hsieh, J.
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Pilot investigation of variants in DNA repair pathways and association with response to platinum-based chemotherapy in bladder cancer

Meeting Abstract

Kopp, R. P.; Stratton, K. L.; Garcia-Grossman, I. R.; Zabor, E. C.; Ostrovnaya, I.; Thomas, T.; Gerber, G.; Alanee, S. R.; Schrader, K. A.; O'Donnell, P. H.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Using exon-capture, deep sequencing of high-grade bladder urothelial carcinoma to identify recurrent genetic alterations and potential therapeutic targets

Meeting Abstract

Kim, P. H.; Sfakianos, J. P.; Scott, S. N.; Iyer, G.; Cha, E. K.; Al-Ahmadie, H.; Sun, A. J.; Garcia-Grossman, I. R.; Bambury, R. M.; Dalbagni, G.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Development and validation of a prognostic nomogram for progression-free and overall survival in patients with advanced renal cell carcinoma (aRCC) treated with pazopanib

Meeting Abstract

Kattan, M. W.; Sternberg, C. N.; Mehmud, F.; Bhatt, K.; Chakrabarti, D.; McCann, L.; Motzer, R. J.
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma

Meeting Abstract

Hakimi, A. A.; Ostrovnaya, I.; Jacobsen, A.; Coleman, J. A.; Russo, P.; Mano, R.; Sankin, A.; Motzer, R. J.; Purdue, M.; Pomerantz, M.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Integrated analysis of metastatic disease in clear cell renal cell carcinoma: A collaborative TCGA analysis

Meeting Abstract

Hakimi, A. A.; Jacobsen, A.; Mano, R.; Gonen, M.; Voss, M. H.; Reuter, V. E.; Rathmell, K.; Maranchie, J. K.; Appleman, L. J.; Tamboli, P.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Mitogen-activated protein kinase (MAPK) pathway mutations impact phenotype and survival in colorectal liver metastases

Meeting Abstract

Frankel, T. L.; Vakiani, E.; DeMatteo, R.; Allen, P.; Fong, Y.; Kingham, T.; Jarnagin, W.; Solit, D.; D'Angelica, M.
Annals of Surgical Oncology (2014)

Fulltext@MSK | Save

Does Gleason score (GS) predict efficacy of abiraterone acetate (AA) therapy in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)? An analysis of AA phase 3 trials

Meeting Abstract

Fizazi, K.; Flaig, T. W.; Ohlmann, C. H.; Scher, H. I.; de Bono, J. S.; Rathkopf, D. E.; Ryan, C. J.; Kheoh, T. S.; Li, J. H.; Todd, M. B.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Evaluating 18F-16 beta-fluoro-5 alpha-dihydrotestosterone (FDHT) and FDG PET as prognostic biomarkers for patients (pts) treated with abiraterone acetate (AA)

Meeting Abstract

Feldman, J. L.; Fox, J. J.; Autio, K. A.; Gavane, S. C.; Heller, G.; Schoder, H.; Humm, J.; Martinez, D. F.; Slovin, S. F.; Scher, H. I.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save